newsfilter
← Latest News
ACCESS Newswire·

Protagonist Reports First Quarter 2025 Financial Results and Provides Corporate Update

Positive top line results from rusfertide Phase 3 VERIFY trial in polycythemia vera announced; full data selected for oral presentation during plenary session at ASCO on June 1stConference call to be held June 2nd